Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS

Bioanalysis

Volumn 6, Issue 9, 2014, Pages 1187-1200

  Wohlfarth, Ariane ^a   Pang, Shaokun ^b   Zhu, Mingshe ^c   Gandhi, Adarsh S ^a,d   Scheidweiler, Karl B ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b MDS SCIEX   (Canada)

^c BRISTOL MYERS SQUIBB   (United States)

^d LUNDBECK RESEARCH USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CYCLOHEXYLETHYL) 3 (2 METHOXYPHENYLACETYL)INDOLE; CANNABINOID DERIVATIVE; UNCLASSIFIED DRUG; 1-(2-CYCLOHEXYLETHYL)-3-(2-METHOXYPHENYLACETYL)INDOLE; CANNABINOID; CYCLOHEXANE DERIVATIVE; INDOLE DERIVATIVE;

ALGORITHM; ANALYTIC METHOD; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DEMETHYLATION; GLUCURONIDATION; HUMAN; HUMAN CELL; LIVER CELL; MASS SPECTROMETER; MASS SPECTROMETRY; METABOLISM; OXIDATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; CHEMISTRY; SYNTHESIS;

CANNABINOIDS; CYCLOHEXANES; HEPATOCYTES; HUMANS; INDOLES; MASS SPECTROMETRY;

EID: 84903195324     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.1     Document Type: Article

References (28)

1. Sedefov R, Gallegos A, Kind L, Lopez D, Auwarter V, Hughes B. Understanding the 'Spice' Phenomenon. EMCDDA 2009 Thematic paper, Lisbon, Portugal (2009).
2. Seely KA, Lapoint J, Moran JH, Fattore L. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog. Neuropsychopharmacol. Biol. Psychiatry 39(2), 234-243 (2012).
3. US Government. Section 1151: Synthetic Drug Abuse Prevention Act of 2012. In: The Food and Drug Administration Safety and Innovation Act (S.3187). (2012).
4. Huffman JW, Szklennik PV, Almond A et al. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorg. Med. Chem. Lett. 15(18), 4110-4113 (2005).
5. Logan BK, Reinhold LE, Xu A, Diamond FX. Identification of synthetic cannabinoids in herbal incense blends in the United States. J. Forensic Sci. 57(5), 1168-1180 (2012).
6. Shanks KG, Dahn T, Behonick G, Terrell A. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry. J. Anal. Toxicol. 36(6), 360-371 (2012).
7. Berrier A. Classes and Structures of Emerging Cannabimimetics and Cathinones. In: Emerging Trends in Synthetic Drugs Workshop Gaithersburg, MD, USA (2013).
8. Wiley JL, Compton DR, Dai D et al. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J. Pharmacol. Exp. Ther. 285(3), 995-1004 (1998).
9. Bluelight Drug User Forum. Thread: 1-(1-(2-cyclohexylethyl)- 1H-indol-3-yl)-2-(2-methoxyphenyl)ethanone 2010. www.bluelight.org/vb/threads/ 510125-1-%281-%282-cyclohexylethyl%29-1H-indol-3-yl%29-22-%282- methoxyphenyl%29ethanone
10. Grigoryev A, Melnik A, Savchuk S, Simonov A, Rozhanets V. Gas and liquid chromatography-mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(25), 2519-2526 (2011).
11. Hutter M, Broecker S, Kneisel S, Auwarter V. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques. J. Mass Spectrom. 47(1), 54-65 (2012).
12. Kavanagh P, Grigoryev A, Melnik A, Simonov A. The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry. J. Anal. Toxicol. 36(5), 303-311 (2012).
13. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of JWH-018 metabolites in smoking mixture postadministration urine. Forensic Sci. Int. 200(1-3), 141-147 (2010).
14. Sobolevsky T, Prasolov I, Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Test. Anal. 4(10), 745-753 (2012).
15. Chimalakonda KC, Moran CL, Kennedy PD et al. Solidphase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Anal. Chem. 83(16), 6381-6388 (2011).
16. Chimalakonda KC, Seely KA, Bratton SM et al. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/spice: identification of novel cannabinoid receptor ligands. Drug Metab. Dispos. 40(11), 2174-2184 (2012).
17. Grigoryev A, Savchuk S, Melnik A et al. Chromatographymass spectrometry studies on the metabolism of synthetic cannabinoids JWH-018 and JWH-073, psychoactive components of smoking mixtures. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(15-16), 1126-1136 (2011).
18. Moran CL, Le VH, Chimalakonda KC et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal. Chem. 83(11), 4228-4236 (2011).
19. Grigoryev A, Kavanagh P, Melnik A. The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatography-mass spectrometry. Drug Test. Anal. 5(2), 110-115 (2012).
20. Hutter M, Moosmann B, Kneisel S, Auwarter V. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism. J. Mass Spectrom. 48(7), 885-894 (2013).
21. Grigoryev A, Kavanagh P, Melnik A. The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry. Drug Test. Anal. 4(6), 519-524 (2012).
22. Grigoryev A, Kavanagh P, Melnik A, Savchuk S, Simonov A. Gas and liquid chromatography-mass spectrometry detection of the urinary metabolites of UR-144 and its major pyrolysis product. J. Anal. Toxicol. 37(5), 265-276 (2013).
23. Gandhi As, Zhu M, Pang S et al. First Characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. AAPS J. 15(4), 1091-1098 (2013).
24. Wohlfarth A, Pang S, Zhu M et al. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clin. Chem. 59(11), 1638-1648 (2013).
25. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y. URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products. Forensic Sci. Int. 227(1-3), 21-32 (2013).
26. Molinspiration Cheminformatics (2013). www.molinspiration.com
27. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 44(5), 832-837 (2009).
28. Steup C. Untersuchung des Handelsproduktes 'SPICE'. THC Pharm GmbH. http://usualredant.de/downloads/analyse-thc-pharm-spice-jwh-018.pdf